Blog

Leaning toward active management (and their proactive research format) are probably better candidates to find the scientific winners to produce the COVID-19 vaccine we need. The point is that our portfolios should reflect a slight bias to active investment management versus passive (ETFs, or exchange-traded funds).

A few very trusted strategies are worth reviewing again and putting them back to work in your investment account, such as dollar cost averaging.

Are the top news providers creating headlines to capture market share? More in-depth information on gains in accelerating vaccine development might be of greater value to readers.

This article, published in DOD News, provides an overview of "Operation Warp Speed," a national effort to accelerate the manufacturing of a COVID-19 vaccine. 

It appears that a stock market recovery is underway.

There is plenty of evidence appearing on a fairly regular basis that confirms the recovery is underway. 

The coronavirus and every aspect of its growth or retreat continue to be red meat for the news writers and broadcasters. 

If you read between the headlines these days, there are actually some words of encouragement.

There are many comparisons being made these days to World War II. We're fighting a global battle with very challenging and powerful fronts: the health front, and the economic front.

The “coronavirus downturn” is delivering some significant buying opportunities.  Recognizing the sell-offs’ value could help reposition portfolios to recoup recent losses.